Bioactivity | Sigma-1 receptor antagonist 4 (Compound 32) is a potent σ1R antagonist that significantly enhances the analgesic effect of morphine and rescues morphine-induced analgesic tolerance, with therapeutic potential to prevent morphine tolerance[1]. |
Target | IC50: 19.1 ± 0.6 nM (σ1R) |
In Vivo | Sigma-1 receptor antagonist 4(0–60 mg/kg;腹腔注射;单次剂量)在 40 mg/kg 剂量范围内以剂量依赖性方式增强吗啡诱导的镇痛作用[1]。Sigma-1 receptor antagonist 4(30 mg/kg;腹腔注射;单剂量)通过增强吗啡诱导的 MOR 激动作用来增强抗伤害作用[1]。 Animal Model: |
Name | Sigma-1 receptor antagonist 4 |
Formula | C22H26N2O |
Molar Mass | 334.45 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Fu K, et al. 2,6-diazaspiro[3.4]octan-7-one derivatives as potent sigma-1 receptor antagonists that enhanced the antinociceptive effect of morphine and rescued morphine tolerance. Eur J Med Chem. 2023 Mar 5;249:115178. |